C333H, a Novel PPARalpha/gamma Dual Agonist, Has Beneficial Effects on Insulin Resistance and Lipid Metabolism1
Acta Pharmacologica Sinica - United Kingdom
doi 10.1111/j.1745-7254.2006.00263.x
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2006
Authors
Publisher
Springer Nature